Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000426773

Medchemexpress LLC DAMGO TFA | 950492-85-0 | 99.5% | 627.61 | 25 MG
SDP

Catalog No. 5000426773
Encompass_Preferred

DAMGO TFA is a selective agonist for the μ-opioid receptor (μ-OPR) with a Kd of 3.46 nM for native μ-OPR. It significantly reduces the activation of neuronal Akt and ERK1/2 by CXCL12 and inhibits CXCL12-promoted neuronal survival, without down-regulating CXCR4 protein expression. It is for research use only.

  • Effectively inhibits prostaglandin E2 (PGE2) induced increase in a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R INa).
  • Produces significant anti-injury effects.
  • Exhibits long-lasting analgesic effects in a dose-dependent manner.

Catalog No. 50-004-26773 Supplier Medchemexpress LLC Supplier No. 25MGHYP0210B
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

DAMGO TFA is a selective agonist for the μ-opioid receptor (μ-OPR) with a Kd of 3.46 nM for native μ-OPR. It significantly reduces the activation of neuronal Akt and ERK1/2 by CXCL12 and inhibits CXCL12-promoted neuronal survival, without down-regulating CXCR4 protein expression. It is for research use only.

  • Effectively inhibits prostaglandin E2 (PGE2) induced increase in a tetrodotoxin-resistant voltage-gated Na+ current (TTX-R INa).
  • Produces significant anti-injury effects.
  • Exhibits long-lasting analgesic effects in a dose-dependent manner.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.